Anavex Life Sciences
AVXL
#7501
Rank
โ‚ฌ0.35 B
Marketcap
3,96ย โ‚ฌ
Share price
-4.28%
Change (1 day)
-56.17%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚ฌ42.2 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ43.5 Million a decrease over its 2023 earnings that were of -โ‚ฌ37.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ42.2 Million-2.99%
2024 -โ‚ฌ43.5 Million14.77%
2023 -โ‚ฌ37.9 Million-17.49%
2022 -โ‚ฌ45.93 Million22.96%
2021 -โ‚ฌ37.35 Million35.36%
2020 -โ‚ฌ27.6 Million12.65%
2019 -โ‚ฌ24.5 Million29.09%
2018 -โ‚ฌ18.98 Million36.33%
2017 -โ‚ฌ13.92 Million17.11%
2016 -โ‚ฌ11.89 Million20.91%
2015 -โ‚ฌ9.83 Million-6.29%
2014 -โ‚ฌ10.49 Million337.28%
2013 -โ‚ฌ2.4 Million
2008 -โ‚ฌ4.44 Million106.01%
2007 -โ‚ฌ2.16 Million8848.98%
2006 -โ‚ฌ0.03 Million-79.99%
2005 -โ‚ฌ0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ56.34 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ55.31 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.05 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.59 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA